239 related articles for article (PubMed ID: 28572257)
1. Translational Genomics: Practical Applications of the Genomic Revolution in Breast Cancer.
Yates LR; Desmedt C
Clin Cancer Res; 2017 Jun; 23(11):2630-2639. PubMed ID: 28572257
[TBL] [Abstract][Full Text] [Related]
2. Unmet Needs in Clinical Research in Breast Cancer: Where Do We Need to Go?
Partridge AH; Carey LA
Clin Cancer Res; 2017 Jun; 23(11):2611-2616. PubMed ID: 28572255
[TBL] [Abstract][Full Text] [Related]
3. Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies.
Ross JS; Gay LM; Wang K; Ali SM; Chumsri S; Elvin JA; Bose R; Vergilio JA; Suh J; Yelensky R; Lipson D; Chmielecki J; Waintraub S; Leyland-Jones B; Miller VA; Stephens PJ
Cancer; 2016 Sep; 122(17):2654-62. PubMed ID: 27284958
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral heterogeneity and subclonal diversification of early breast cancer.
Yates LR
Breast; 2017 Aug; 34 Suppl 1():S36-S42. PubMed ID: 28666921
[TBL] [Abstract][Full Text] [Related]
5. Catalog of genetic progression of human cancers: breast cancer.
Desmedt C; Yates L; Kulka J
Cancer Metastasis Rev; 2016 Mar; 35(1):49-62. PubMed ID: 26951551
[TBL] [Abstract][Full Text] [Related]
6. The genomic landscape of breast cancer and its interaction with host immunity.
Luen S; Virassamy B; Savas P; Salgado R; Loi S
Breast; 2016 Oct; 29():241-50. PubMed ID: 27481651
[TBL] [Abstract][Full Text] [Related]
7. Genomic profiling of breast cancers.
Curtis C
Curr Opin Obstet Gynecol; 2015 Feb; 27(1):34-9. PubMed ID: 25502431
[TBL] [Abstract][Full Text] [Related]
8. Deciphering and Targeting Oncogenic Mutations and Pathways in Breast Cancer.
Santarpia L; Bottai G; Kelly CM; Győrffy B; Székely B; Pusztai L
Oncologist; 2016 Sep; 21(9):1063-78. PubMed ID: 27384237
[TBL] [Abstract][Full Text] [Related]
9. The Dawning of Translational Breast Cancer: From Bench to Bedside.
Chen X; Fan S; Song E
Adv Exp Med Biol; 2017; 1026():1-25. PubMed ID: 29282677
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer genomics from microarrays to massively parallel sequencing: paradigms and new insights.
Ng CK; Schultheis AM; Bidard FC; Weigelt B; Reis-Filho JS
J Natl Cancer Inst; 2015 Feb; 107(5):. PubMed ID: 25713166
[TBL] [Abstract][Full Text] [Related]
11. The Genomic Landscape of Male Breast Cancers.
Piscuoglio S; Ng CK; Murray MP; Guerini-Rocco E; Martelotto LG; Geyer FC; Bidard FC; Berman S; Fusco N; Sakr RA; Eberle CA; De Mattos-Arruda L; Macedo GS; Akram M; Baslan T; Hicks JB; King TA; Brogi E; Norton L; Weigelt B; Hudis CA; Reis-Filho JS
Clin Cancer Res; 2016 Aug; 22(16):4045-56. PubMed ID: 26960396
[TBL] [Abstract][Full Text] [Related]
12. Genomic Pathology and Biomarkers in Breast Cancer.
Zhang Z; Tang P
Crit Rev Oncog; 2017; 22(5-6):411-426. PubMed ID: 29604921
[TBL] [Abstract][Full Text] [Related]
13. Comparative genomic analysis of primary tumors and metastases in breast cancer.
Bertucci F; Finetti P; Guille A; Adélaïde J; Garnier S; Carbuccia N; Monneur A; Charafe-Jauffret E; Goncalves A; Viens P; Birnbaum D; Chaffanet M
Oncotarget; 2016 May; 7(19):27208-19. PubMed ID: 27028851
[TBL] [Abstract][Full Text] [Related]
14. Mutational Signatures in Breast Cancer: The Problem at the DNA Level.
Nik-Zainal S; Morganella S
Clin Cancer Res; 2017 Jun; 23(11):2617-2629. PubMed ID: 28572256
[TBL] [Abstract][Full Text] [Related]
15. Gene-Expression-Based Predictors for Breast Cancer.
Gupta A; Mutebi M; Bardia A
Ann Surg Oncol; 2015 Oct; 22(11):3418-32. PubMed ID: 26215189
[TBL] [Abstract][Full Text] [Related]
16. Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance.
Saunus JM; Quinn MC; Patch AM; Pearson JV; Bailey PJ; Nones K; McCart Reed AE; Miller D; Wilson PJ; Al-Ejeh F; Mariasegaram M; Lau Q; Withers T; Jeffree RL; Reid LE; Da Silva L; Matsika A; Niland CM; Cummings MC; Bruxner TJ; Christ AN; Harliwong I; Idrisoglu S; Manning S; Nourse C; Nourbakhsh E; Wani S; Anderson MJ; Fink JL; Holmes O; Kazakoff S; Leonard C; Newell F; Taylor D; Waddell N; Wood S; Xu Q; Kassahn KS; Narayanan V; Taib NA; Teo SH; Chow YP; kConFab ; Jat PS; Brandner S; Flanagan AM; Khanna KK; Chenevix-Trench G; Grimmond SM; Simpson PT; Waddell N; Lakhani SR
J Pathol; 2015 Nov; 237(3):363-78. PubMed ID: 26172396
[TBL] [Abstract][Full Text] [Related]
17. Dynamic genome and transcriptional network-based biomarkers and drugs: precision in breast cancer therapy.
Kyrochristos ID; Ziogas DE; Roukos DH
Med Res Rev; 2019 May; 39(3):1205-1227. PubMed ID: 30417574
[TBL] [Abstract][Full Text] [Related]
18. What to expect from high throughput genomics in metastatic breast cancers?
Onesti CE; Vicier C; André F
Breast; 2015 Nov; 24 Suppl 2():S19-22. PubMed ID: 26238439
[TBL] [Abstract][Full Text] [Related]
19. Precision medicine in breast cancer: genes, genomes, and the future of genomically driven treatments.
Stover DG; Wagle N
Curr Oncol Rep; 2015 Apr; 17(4):15. PubMed ID: 25708799
[TBL] [Abstract][Full Text] [Related]
20. Genomic and transcriptional heterogeneity-based precision in personalized treatment for breast cancer.
Antoniou P; Ziogas DE; Vlachioti A; Lykoudis EG; Mitsis M; Roukos DH
Per Med; 2019 Sep; 16(5):361-364. PubMed ID: 31507233
[No Abstract] [Full Text] [Related]
[Next] [New Search]